secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001193125-25-300647
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics appoints James R. Meyers to Board of Directors
----------------------------------------------------------------

- James R. Meyers appointed as Class II Director effective Nov 25, 2025; term expires at 2026 annual meeting.
- Appointed to Audit Committee; received nonstatutory stock option for 25,000 shares vesting monthly over 3 years.
- Annual cash retainer of $40k plus $10k Audit Committee retainer, pro-rated for 2025.
- Eligible for annual option grant at 2026 meeting: lesser of 14,000 shares or fair value not exceeding $400,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312525300647/0001193125-25-300647-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312525300647/vera-20251125.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-300647

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer